Probity Medical Research
Probity Medical Research is a privately held consortium of 60+ clinical research sites across the USA, Canada, Australia, and Chile that provides pharmaceutical sponsors, CROs, and affiliated investigators with access to a multi-country site network for Phase I-IV clinical trials and bundled operational support services.
- Company typePrivate
- Founded1995
- HeadquartersWaterloo, Canada
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Probity Medical Research does
Probity Medical Research Inc. (PMR), founded in 1995 in Waterloo, Ontario, Canada, operates as a consortium of clinical research sites that provides pharmaceutical sponsors, contract research organizations (CROs), and affiliated investigators with access to a multi-country network for Phase I-IV clinical trial execution. The company began with a single dermatology site and has grown to encompass 60+ high-performance sites across the USA, Canada, Australia, and Chile, spanning dermatology, cardiology, allergy, and clinical immunology. PMR reports 1,250+ unique clinical trials conducted, 40,000+ participants enrolled, 56 regulatory inspections passed (FDA, Health Canada, EMEA), and KOL investigators who have consulted for 270+ pharmaceutical companies.
PMR's core offering bundles a clinical trial management platform with site-level support services, including site training and consultation, administrative and regulatory document support, financial and budget services, and business networking across the consortium. Its business model is professional services-based: revenue is generated through negotiated, per-engagement contracts with pharmaceutical sponsors, CROs, and affiliated clinic partners for access to the site network and operational support. Pricing is not publicly disclosed, and go-to-market is direct enterprise outreach via the company's website contact channel. PMR is a privately held Ontario corporation with no disclosed external investors, parent company, or public listing.
The company's competitive position is anchored in network effects (60+ sites across four countries), a talent moat (KOL investigators with pharma consulting experience), and a regulatory moat (multi-jurisdiction inspection track record). PMR has no published AI/ML capabilities, no disclosed funding rounds, no M&A activity, and no public management team; the leadership layer is not visible in available source data.
Probity Medical Research firmographics
Firmographics- Name
- Probity Medical Research
- Legal name
- Probity Medical Research Inc.
- Website
- https://probitymedical.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Probity Medical Research is a privately held consortium of 60+ clinical research sites across the USA, Canada, Australia, and Chile that provides pharmaceutical sponsors, CROs, and affiliated investigators with access to a multi-country site network for Phase I-IV clinical trials and bundled operational support services.
- Ownership category
- akta.pro rank
Probity Medical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Clinical Trial Financial Management & Payments (Site Budgeting) (HLAGACAM)
Keywords
Where Probity Medical Research is headquartered
LocationHeadquarters
- HQ city
- Waterloo
- HQ country
- Canada
- HQ region
- North America
Offices13 records
Markets served
Probity Medical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Clinical Research Site Services: PMR generates revenue by providing clinical research site support services to study sponsors, CROs, and clinic partners. Services include access to their consortium of international sites, site training, administrative support, regulatory document management, financial services, and study opportunity matching.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Probity Medical Research product offering
Product offeringCore offering
Probity Medical Research operates a consortium of more than 60 high-performance clinical research sites across the USA, Canada, Australia, and Chile. The company provides study sponsors and contract research organizations with access to this site network for clinical trial execution, while supplying member sites with a Clinical Trial Management Platform and shared support services including training, consultation, administrative support, business networking, regulatory documents, and financial services.
Product overview
Probity Medical Research Inc. (PMR) operates as a clinical research site network consortium offering a unified platform of support services. The core offering includes access to a clinical trial management platform, combined with site training, administrative support, business networking, regulatory document services, and financial services. PMR maintains a consortium of over 60 high-performance research sites across dermatology, cardiology, allergy, and other specialties in USA, Canada, Australia, and Chile, providing study sponsors access to international site network for Phase I-IV clinical trials.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Site Consortium Network
Quantifiable outcome
- Consistently top-enrolling sites in clinical trials
- +1 more outcomes
Companies that use Probity Medical Research
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Probity Medical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Probity Medical Research partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Pharmaceutical Companies (Study Sponsors)corePMR provides pharmaceutical sponsors access to their consortium of 60+ high-performance clinical research sites across USA, Canada, Australia, and Chile for Phase I-IV clinical trial execution.
- Contract Research Organizations (CROs)coreCROs partner with PMR to access site network for clinical trial feasibility, site selection, and study execution support.
- Clinical Research Sites (Affiliated Investigators)corePMR supports affiliated clinical research sites and investigators by providing study opportunities, training, administrative support, regulatory documents, financial services, and business networking.
Scale indicators11 records
Recent moves4 records
Expansion highlights4 records
Probity Medical Research competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is a global CRO incumbent with its own site network and technology platform, providing broader-scale competition to PMR's clinical trial site services.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO that combines site management with full-service trial execution, offering overlapping capabilities to PMR's network on a broader scale.
- Charles River Laboratories: Charles River offers integrated clinical research site services as part of a broader CRO/preclinical portfolio, operating at a different scale than PMR but providing overlapping site capabilities.
Direct peers
- Synexus (PPD/Thermo Fisher): Synexus is one of the world's largest site networks, originally an independent SMO comparable to PMR before PPD acquisition, providing multi-country clinical trial site access for sponsors.
- CenExel: CenExel runs a network of specialty clinical research sites across multiple therapeutic areas, comparable to PMR's multi-specialty site consortium serving pharmaceutical and biotech sponsors.
- Optimal Research: Optimal Research operates multi-therapeutic clinical research sites in the US, comparable to PMR's site network delivering Phase I-IV trial execution for sponsors and CROs.
- Velocity Clinical Research: Velocity operates a large US-based network of wholly-owned clinical research sites, directly comparable to PMR's consortium model of multi-site clinical trial execution for sponsors and CROs.
- IACT Health: IACT Health is an integrated SMO with a portfolio of clinical research sites, directly comparable to PMR's multi-site consortium model serving pharmaceutical sponsors.
- CTI Clinical Trial and Consulting Services: CTI operates dedicated clinical research centers and supporting services, comparable to PMR's site consortium model delivering site operations and trial management across multiple specialties.
Emerging players
- ProSciento: ProSciento is a specialty clinical research site network focused on metabolic disease, overlapping with PMR's specialty site network model but with a narrower therapeutic focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Probity Medical Research social profiles
Digital presenceProbity Medical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Probity Medical Research leadership team
Management profileNumber of profiles
Probity Medical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Probity Medical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Probity Medical Research
What does Probity Medical Research do?
Probity Medical Research operates a consortium of more than 60 high-performance clinical research sites across the USA, Canada, Australia, and Chile. The company provides study sponsors and contract research organizations with access to this site network for clinical trial execution, while supplying member sites with a Clinical Trial Management Platform and shared support services including training, consultation, administrative support, business networking, regulatory documents, and financial services.
Is Probity Medical Research a public or private company?
Probity Medical Research is a private company. It is classified as unknown and is currently operating.
When was Probity Medical Research founded?
Probity Medical Research was founded in 1995. It employs 51 to 100 people.
Where is Probity Medical Research based?
Probity Medical Research is headquartered in Waterloo, Canada, in the North America region.
How does Probity Medical Research make money?
One revenue line is on record: clinical Research Site Services.
Who are Probity Medical Research's main competitors?
Broad incumbents on record are IQVIA, Worldwide Clinical Trials and Charles River Laboratories. Direct peers are Synexus (PPD/Thermo Fisher), CenExel, Optimal Research, Velocity Clinical Research, IACT Health and CTI Clinical Trial and Consulting Services. ProSciento is listed as an emerging player.
Does Probity Medical Research have an API?
No public API is recorded for Probity Medical Research.
What industry is Probity Medical Research in?
Probity Medical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5417 and its SIC code is 8731.